The rationale is smoother blood levels, fewer GI side effects from peak concentrations, and more consistent appetite suppression throughout the week
Toft-Nielson M, Madsbad S, Holst JJ
In STEP 1, the phase 3 trial that led to semaglutide's approval for obesity, participants lost about 15% of their body weight over a year
Dietitian-Led Nutrition Program Weekly consultations with certified dietitians
Companies such as Eris, Alkem, and Corona Pharma have also begun to gain traction, while generics from Lupin, Zydus, and Dr Reddys reported lower sales figures in comparison
Many patients find semaglutide to be more effective than phentermine since its both more potent and can be used for longer periods, unlike phentermine which is only meant for short-term treatment.